Hoenle AG (ETR:HNL)
| Market Cap | 57.10M -2.7% |
| Revenue (ttm) | 94.14M -2.3% |
| Net Income | -4.11M |
| EPS | -0.68 |
| Shares Out | 6.06M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 22 |
| Average Volume | 1,192 |
| Open | 9.42 |
| Previous Close | 9.42 |
| Day's Range | 9.42 - 9.44 |
| 52-Week Range | 6.48 - 10.90 |
| Beta | 1.47 |
| RSI | 54.42 |
| Earnings Date | May 19, 2026 |
About Hoenle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives applications. The Curing segment sells equipment for surface drying and curing paints, varnishes, and other coatings for printing, packaging printing,... [Read more]
Financial Performance
In fiscal year 2025, Hoenle AG's revenue was 94.00 million, a decrease of -4.82% compared to the previous year's 98.76 million. Losses were -3.17 million, -76.15% less than in 2024.
Financial StatementsNews
Hoenle AG Earnings Call Transcript: Q2 2026
Revenue and EBITDA improved sequentially, with Adhesive and Disinfection units showing growth, while Curing faced continued challenges from weak investment and customer insolvency. Full-year guidance is maintained, but expectations are toward the lower end due to market uncertainty.
Hoenle AG Quarterly report: Q2 2026
Hoenle AG has published its Q2 2026 quarterly earnings report on May 19, 2026.
Hoenle AG Slides: Company presentation
Hoenle AG has posted slides in relation to its latest quarterly earnings report, which was published on April 7, 2026.
Hoenle AG Earnings Call Transcript: Q1 2026
Revenue and EBITDA were flat to slightly down year-over-year amid industry-wide reluctance, with Disinfection showing strong growth. Management maintains full-year guidance, expecting improved performance in the second half as order intake and after-sales activities increase.
Hoenle AG Earnings Call Transcript: Q1 2026
Q1 sales and EBITDA were flat to slightly down year-over-year, with Disinfection showing strong growth while Curing lagged due to weak investment demand. Full-year guidance is maintained, with expectations for stronger performance in the second half and ongoing cost control.
Hoenle AG Quarterly report: Q1 2026
Hoenle AG has published its Q1 2026 quarterly earnings report on February 24, 2026.
Hoenle AG Slides: Q1 2026
Hoenle AG has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on February 24, 2026.
Hoenle AG Annual report: Q4 2025
Hoenle AG has published its Q4 2025 annual report on January 29, 2026.
Mixed Q3, FY guidance lowered but prospect remain attractive
Dr. Hönle reported Q3 revenue down 5.5% to €22.4m amid weak demand, particularly in adhesives. New FY24/25 guidance lowered; BUY with €16 price target. Jetzt den vollständigen Artikel lesen
Hoenle AG Quarterly report: Q3 2025
Hoenle AG has published its Q3 2025 quarterly earnings report on August 7, 2025.
Hoenle AG Slides: Company Presentation
Hoenle AG has posted slides in relation to its latest quarterly earnings report, which was published on August 7, 2025.